OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review
Silvia Grazzini, Chiara Rizzo, Edoardo Conticini, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 2, pp. 103264-103264
Closed Access | Times Cited: 8
Silvia Grazzini, Chiara Rizzo, Edoardo Conticini, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 2, pp. 103264-103264
Closed Access | Times Cited: 8
Showing 8 citing articles:
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review
Michela Gasparotto, Chiara Franco, Elisabetta Zanatta, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 6, pp. 103334-103334
Open Access | Times Cited: 17
Michela Gasparotto, Chiara Franco, Elisabetta Zanatta, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 6, pp. 103334-103334
Open Access | Times Cited: 17
Janus kinase inhibition (JAKi) therapy in refractory anti-synthetase syndrome: A retrospective cohort study
Xueyan Shan, Shiyu Wu, Xixia Chen, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 68, pp. 152474-152474
Open Access | Times Cited: 8
Xueyan Shan, Shiyu Wu, Xixia Chen, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 68, pp. 152474-152474
Open Access | Times Cited: 8
Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast
Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, et al.
Reumatismo (2025)
Open Access
Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, et al.
Reumatismo (2025)
Open Access
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies
Stefano Stano, Fabio Cacciapaglia, L. Coladonato, et al.
Reumatismo (2025)
Open Access
Stefano Stano, Fabio Cacciapaglia, L. Coladonato, et al.
Reumatismo (2025)
Open Access
Autophagy in myositis, a dysregulated pathway, and a target for therapy
A. S. Kamalanathan, Vikas Agarwal, Laura Talamini, et al.
Autoimmunity Reviews (2025), pp. 103817-103817
Closed Access
A. S. Kamalanathan, Vikas Agarwal, Laura Talamini, et al.
Autoimmunity Reviews (2025), pp. 103817-103817
Closed Access
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: a pilot study.
Edoardo Conticini, Paolo Cameli, Silvia Grazzini, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 69, pp. 152560-152560
Open Access | Times Cited: 1
Edoardo Conticini, Paolo Cameli, Silvia Grazzini, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 69, pp. 152560-152560
Open Access | Times Cited: 1
On the role of anti-cN1A antibodies in sporadic inclusion body myositis and beyond: a challenging task full of surprises
Eleni Patrikiou, Christos Liaskos, Dimitrios P. Bogdanos
Reumatologia/Rheumatology (2024)
Open Access
Eleni Patrikiou, Christos Liaskos, Dimitrios P. Bogdanos
Reumatologia/Rheumatology (2024)
Open Access
Interleukin 6 inhibition in refractory antisynthetase syndrome: case-based literature review
Anna Driesen, Jean‐Baptiste Vulsteke, Luk Corluy, et al.
Acta Clinica Belgica (2024) Vol. 79, Iss. 5, pp. 368-376
Closed Access
Anna Driesen, Jean‐Baptiste Vulsteke, Luk Corluy, et al.
Acta Clinica Belgica (2024) Vol. 79, Iss. 5, pp. 368-376
Closed Access
